Beyond PSA: Promising New Markers for Prostate Cancer
Reference115 articles.
1. Stamey TA. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. Monogr Urol. 1989;10(4):50–64.
2. Stamey TA, Caldwell M, McNeal JE, Nolley R, Hemenez M, Downs J. The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol. 2004;172(4 Pt 1):1297–301.
3. Gutman AB, Gutman EB. An “acid” phosphatase occurring in the serum of patients with metastasizing carcinoma of the prostate gland. J Clin Invest. 1938;17(4):473–8.
4. Huggins C, Stevens RA, Hodges CV. Studies on prostate cancer. The effects of castration on advanced carcinoma of the prostate gland. Arch Surg. 1941;43:209–23.
5. Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer. 2005;5(11):845–56.